Novartis (NVS) Tops Q3 EPS by 6c; raises 2023 outlook

Novartis (NYSE: NVS) reported Q3 EPS of $1.74, $0.06 better than the analyst estimate of $1.68. Revenue for the quarter came in at $11.78 billion versus the consensus estimate of $13.08 billion.

OUTLOOK:

Net sales Expected to grow high single digit.

For earnings history and earnings-related data on Novartis (NVS) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Pfizer lung cancer drug misses survival goal in Phase 3 trial
• NVE Corporation names new CEO and expands board to seven members